Dafalgan Grippal
Dafalgan Grippal is a medicine authorised by Swissmedic under authorisation number 67691. The authorisation holder is UPSA Switzerland AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 04 February 2021 and the authorisation is valid without a time limit. ATC code N02BE51 places the medicine in the group Analgesics.
| Authorisation number | 67691 |
|---|---|
| Name | Dafalgan Grippal |
| Full name | Dafalgan Grippal, Granulat zur Herstellung einer Lösung zum Einnehmen |
| Authorisation holder | UPSA Switzerland AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | N02BE51 |
| First authorisation | 04 February 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dafalgan Grippal, Granulat zur Herstellung einer Lösung zum Einnehmen | D | 04 February 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 12 | Beutel | N02BE51 | 01.01.2. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dafalgan Grippal authorised in Switzerland?
Yes. Dafalgan Grippal is authorised by Swissmedic under authorisation number 67691, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dafalgan Grippal have?
Dafalgan Grippal is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Dafalgan Grippal?
The authorisation holder is UPSA Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.